Current view of the Epstein-Barr virus infection


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Epstein-Barr virus (EBV) is one of the most common human viruses that persists in more than 90-95% of the world’s population over 40 years old and is considered the main cause of infectious mononucleosis (IM). The extremely high prevalence of EBV infection among people and the high risk of developing related conditions raise the issue of further close study of the virus to one of the leading positions. The article provides information on the epidemiology, clinical picture, diagnosis and treatment of this disease.

Texto integral

Acesso é fechado

Sobre autores

A. Polyakova

National Medical Research Center for Children's Health; Pirogov Russian National Research Medical University

Email: darmanyan@nczd.ru

M. Bakradze

National Medical Research Center for Children's Health

G. Dzhivanshiryan

National Medical Research Center for Children's Health

V. Tatochenko

National Medical Research Center for Children's Health

Bibliografia

  1. Кан Н.Ю. Клинико-патогенетическое значение влияния Эпштейна-Барр вирусной инфекции и цитомегаловируса на систему мононуклеарных фагоцитов у детей - реконвалесцентов инфекционного мононуклеоза. Дисс. канд. мед. наук. М., 2017
  2. Smatti M.K, Al-Sadeq D.W., Ali N.H., Pintus G., et al. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front. Oncol. 2018;8:211. doi: 10.3389/fonc.2018.00211.
  3. Некоммерческое партнерство «Национальное научное общество инфекционистов». Клинические рекомендации инфекционный мононуклеоз у взрослых. ФГБУ «НИИ вирусологии им. Д.И. Ивановского» МЗ РФ, 2014. С. 1-74.
  4. Womack J., Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91(6):372-76.
  5. Bu W, Hayes G.M., Liu H., et al. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV Clin Vaccine Immunol. 2016;23(4):363-69. doi: 10.1128/CVI.00674-15. Print 2016 Apr.
  6. Devkota K, He M., Liu M.Y, et al. Increasing Epstein-Barr virus infection in Chinese children: A single institutional based retrospective study. Version 2. F1000. Res. 2018 Aug 7 [revised 2019 Feb 15];7:1211. Doi: 10.12688/ f1000research.15544.2.
  7. Draborg A.H., Duus K., Houen G. Epstein-Barr Virus in Systemic Autoimmune Diseases. Clin Dev Immunol. 2013;2013:535738. doi: 10.1155/2013/535 738.
  8. Schuster V., Kreth H.W. Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects. Eur J Pediatr. 1992;151(10):718-25.
  9. Берман Р.Э., Клигман Р.М., Дженсон Х.Б. Педиатрия по Нельсону 17-е издание. М., 2009. Т. 3. 1182 с
  10. Lennon P, Crotty M., Fenton J.E. Infectious mononucleosis. Cite this as: BMJ.2015;350:h1825. doi: 10.1136/bmj.h1825.
  11. Dunmire S.K., Hogquist K.A., Balfour H.H. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390:211-40. doi: 10.1007/978-3-319-22822-8_9.
  12. Venkitaraman A.R., Lenoir G.M., John T.J. The seroepidemiology of infection due to Epstein-Barr virus in southern India. J Med Virol. 1985;15(1):11-6.
  13. Fourcade G., Germi R., Guerber F, et al. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016. PloS One. 2017;12(4):e0175574. doi: 10.1371/journal.pone.0175574.
  14. Михнева С.А., Гришина Ю.Ю., Кухтевич Е.В., Мартынов Ю.В. Инфекционный мононулеоз: характеристика проявлений эпидемического процесса. Инфекционные болезни: новости, мнения, обучение. 2017;5:61-4.
  15. Bravender T. Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc Med State Art Rev. 2010;21(2):251-64.
  16. Fafi-Kremer S., Morand I3, Brion J.P, et al. Longterm shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis. 2005;191(6):985-89.
  17. Luzuriaga K., Sullivan J.L. Infectious mononucleosis. N Engl J Med. 2010;362(21):1993-2000. doi: 10.1056/NFJMcp1001116.
  18. Fugl A.C. Lykkegaard Andersen Epstein-Barr virus and its association with disease - a review of relevance to general practice BMC. Family Pract. 2019;20(Article 62).
  19. Tattevin P, Le Tulzo Y, Minjolle S., et al. Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study J Clin Microbiol. 2006;44(5):1873-74. Doi: 10.1128/ JCM.44.5.1873- 74.2006.
  20. Crawford D.H., Macsween K.F., Higgins C.D., et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis. 2006;43(3):276-82.
  21. Sarwari N.M., Khoury J.D., Hernandez C.M. Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma. BMC. Hematol. 2016;16:19. doi: 10.1186/s12878-016-0059-3.
  22. Hoagland R.J. Infectious mononucleosis. Prim Care. 1975;2(2):295-307.
  23. Lennon P, O' Neill J.P, Fenton J.E., O' Dwyer T. Challenging the use of the lymphocyte to white cell count ratio in the diagnosis of infectious mononucleosis by analysis of a large cohort of Monospot test results. Clin Otolaryngol. 2010;35(5):397-401. doi: 10.1111/j.1749-4486.2010.02187.x.
  24. Kofteridis D.P, Koulentaki M., Valachis A., et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22(1):73-6. Doi: 10.1016/j. ejim.2010.07.016.
  25. Hosey R.G., Kriss V., Uhl T.L., et al. Ultrasonographic evaluation of splenic enlargement in athletes with acute infectious mononucleosis. Br J Sports Med. 2008;42(12):974-77. Doi: 10.1136/ bjsm.2008.050807.
  26. Chovel-Sella A., Ben Tov A., Lahav E., et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatr. 2013;131(5):e1424-27. Doi: 10.1542/ peds.2012-1575.
  27. Thompson D.F, Ramos C.L. Antibiotic-Induced Rash in Patients With Infectious Mononucleosis. Ann Pharmacother. 2017;51(2):154-162. doi: 10.1177/1060028016669525.
  28. Candy B., Chalder T., Cleare A.J., et al. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract. 2002;52(483):844-51.
  29. Rafailidis P.I.,Mavros M.N.,Kapaskelis A.,Falagas M.E. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol. 2010;49(3):151-57.
  30. Bartlett A., Williams R., Hilton M. Splenic rupture in infectious mononucleosis: A systematic review of published case reports. Injury. 2016;47(3):531-doi: 10.1016/j.injury.2015.10.071.
  31. Heo D.H., Baek D.Y., Oh S.M., et al. Splenic infarction associated with acute infectious mononucleosis due to Epstein-Barr virus infection. J Med Virol. 2017;89(2):332-36. Doi: 10.1002/ jmv.24618.
  32. Боковой А.Г., Ковалев И.В., Таратина М.Э., Ломрачева М.Е. Определение АМ в крови как диагностический тест на герпесвирусные инфекции у детей. Детские инфекции. 2006;2:70-2.
  33. Дарманян А.С. Совершенствование методов диагностики и лечения острых тонзиллитов у детей. Научный центр здоровья детей РАМН. М., 2010
  34. Stuempfig N.D., Seroy J. Monospot Test. StatPearls [internet]. Treasure Island (FL): Stat Pearls Publishing. 2019 Mar 10.
  35. Vouloumanou E.K., Rafailidis Pi., Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20. Doi: 10.1097/ MOH.0b013e32834daa08.
  36. De Paor M, O'Brien K., Fahey T., Smith S.M. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database Syst Rev. 2016;8(12):CD011487. doi: 10.1002/14651858.CD011487.pub2.
  37. Ebell M.H. Epstein-Barr Virus infectious Mononucleosis. Am Fam.Physician. 2004;70(7):1279-87.
  38. Chhabra P, Law A.D., Sharma U., et al. Epstein-barr virus infection masquerading as acute leukemia: a report of two cases and review of literature. indian J. Hematol. Blood Transfus. 2014;30(1):26-8. doi: 10.1007/s12288-012-0207-2.
  39. Якушина С.А., Кистенева Л.Б. Влияние персистенции вируса Эпштейна-Барр на развитие иммуноопосредованных соматических заболеваний. Обзор литературы. Российский вестник перинатологии и педиатрии. 2018;63:22-6.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies